Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Use of Tumor Markers Low in Testis Cancer
Link ID 4347
Title Use of Tumor Markers Low in Testis Cancer
Url http://www.medscape.com/viewarticle/572047?src=rss
Description The use of tumor markers in testis cancer is low and varies considerably in the United States, despite the role markers can play in providing information pertinent to diagnosis, risk stratification, response to therapy, and disease recurrence. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Mar 28, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. High-Dose Chemotherapy No Better Than Standard Dose in Small-Cell Lung Cancer
  Dose intensification of chemotherapy should now be abandoned as a strategy, because there is no benefit but markedly more toxicity with this approach. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Tobacco-Related Cancer Cases Top 2 Million
  More than 2 million cases of cancer related to tobacco were diagnosed in the United States from 1999 to 2004, says CDC WebMD Health News
Category:   Articles > Hematology-Oncology


3. Height May Be a Risk Factor for Prostate Cancer
  Taller men and those with longer leg-to-trunk height ratios may be at slightly increased risk for prostate cancer overall, and for high-grade cancer in particular, suggest results of a case-control study and meta-analysis. But the finding, while interesting, does not suggest a need for changes in screening or treatment, and should not be of concern to basketball players or other tall men. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Vitamin D May Not Decrease Risk for Prostate Cancer
  In a large prospective study, higher circulating serum concentrations of 25-hydroxyvitamin D were associated with an increased risk for aggressive prostate cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. European Regulators Say Transfusions Safer Than ESAs in Cancer
  In a startling recommendation, the European Medicines Agency is urging oncologists to favor transfusions over erythropoiesis-stimulating agents. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS